Ozempic’s potential in delaying insulin in new type 1 diabetes patients

Image credit: sweetlifediabetes via Unsplash

Recent research published in The New England Journal of Medicine offers hope for those newly diagnosed with type 1 diabetes, indicating that the drug in Ozempic might allow these patients to delay or potentially avoid the immediate need for insulin injections. While the findings are still preliminary, they present a promising area for further research. If these results can be confirmed in larger clinical trials, this could present a significant advancement in type 1 diabetes treatments.

Source

Tirrell, Meg. “Drug in Ozempic May Enable Patients with Newly Diagnosed Type 1 Diabetes to Stave off Insulin Use, Small Study Suggests.” CNN, Cable News Network, 8 Sept. 2023, www.cnn.com/2023/09/08/health/ozempic-diabetes-semaglutide-study/index.html#:~:text=A%20weekly%20dose%20of%20semaglutide,months%20in%20a%20small%20study.